What Could a New Drug Approval Mean for CLL Patients?

Dr. William Wierda, medical director of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, joins Patient Power to discuss the approval of Venclexta (venetoclax) for use i... Author: patientpower Added: 04/13/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts